US Patent 8962602 Anticancer steroidal lactones unsaturated in position 7 (8)
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+147 characters)
Article
Patent abstract
A compound of general formula (I), wherein R1-R17 and the - - - - - - line take various meanings for use in the treatment of cancer.
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Andrés Francesch Solloso0
José Fernando Reyes Benítez0
María del Carmen Cuevas Marchante0
Rogelio Fernández Rodríguez0
Edits on 2 Aug, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08962602 Anticancer steroidal lactones unsaturated in position 7 (8) US Patent 8962602 Anticancer steroidal lactones unsaturated in position 7 (8)
Infobox
Patent Number
089626020
Patent Number
89626020
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
089626020
Date of Patent
February 24, 2015
0Patent Application Number
136429100
Date Filed
April 26, 2011
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 29 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 08962602 Anticancer steroidal lactones unsaturated in position 7 (8)
Infobox
Is a
Patent jurisdiction
Patent number
08962602
Date of patent
February 24, 2015
Patent application number
13642910
Date Filed
April 26, 2011
Patent primary examiner
Find more entities like US Patent 8962602 Anticancer steroidal lactones unsaturated in position 7 (8)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
